U.S. federal trademark · Serial No. 97525656
Pharmaceutical preparations for the treatment of neurological, renal, hematopoietic, thyroid, and ophthalmic diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Anti-inflammatory pharmaceutical preparations; Cardiovascular pharmaceuticals; anti-neoplastic pharmaceutical preparations; immunomodulatory pharmaceutical preparations; hematopoietic pharmaceutical preparations; pharmaceutical preparations, namely, thrombolytic agents; antiplatelets, namely, platelet agglutination inhibitors and platelet aggregation inhibitors; Estrogen preparations; pharmaceutical preparations, namely, progestin; Androgen preparations; Antithyroid pharmaceutical preparations used to treat hyperthyroidism; Pharmaceutical preparations for treating diabetes; pharmaceutical preparations used to treat gastro-intestinal diseases and disorders, namely, histamine H2 receptor antagonists and proton pump antagonists; anti-emetic pharmaceutical preparations; anti-convulsant pharmaceutical preparations; pharmaceutical preparations for the treatment of asthma; anti-diabetic pharmaceuticals; all of the foregoing for human use
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.